Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John McCall

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Aging|July 8, 2016
A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblastsTasnuva D Kabir, Ross J Leigh, Hataitip Tasena, et al.
Cancers|June 10, 2022
Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0Savio G Barreto, Simone I Strasser, Geoffrey W McCaughan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2012
Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effectsAndreas R Baudy, Erica K M Reeves, Jesse M Damsker, et al.
Nature Communications|January 19, 2018
∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingHamish Campbell, Nicholas Fleming, Imogen Roth, et al.
The Medical Journal of Australia|October 5, 2020
Outcomes for children after second liver transplantations are similar to those after first transplantations: a binational registry analysisAngus W Jeffrey, Gary P Jeffrey, Michael Stormon, et al.
Clinical Transplantation|December 13, 2023
Impact of Share 35 liver transplantation allocation in Australia and New ZealandMichael A Fink, Paul J Gow, Geoffrey W McCaughan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasisJoseph D Turner, Raman Sharma, Ghaith Al Jayoussi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2025
Incidence and risk factors for portal vein complications after pediatric liver transplantation: A retrospective cohort analysis from the PORTAL registryBader A Alfares, Lydia Sieben, Weihao Li, et al.
The New Zealand Medical Journal|February 17, 2017
Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?Boyd Swinburn, Stefanie Vandevijvere, Alistair Woodward, et al.
BMJ Open|July 27, 2023
Prevalence, management and efficacy of treatment in portal vein obstruction after paediatric liver transplantation: protocol of the retrospective international multicentre PORTAL registryBader A Alfares, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Aging|July 8, 2016
A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblastsTasnuva D Kabir, Ross J Leigh, Hataitip Tasena, et al.
Cancers|June 10, 2022
Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0Savio G Barreto, Simone I Strasser, Geoffrey W McCaughan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2012
Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effectsAndreas R Baudy, Erica K M Reeves, Jesse M Damsker, et al.
Nature Communications|January 19, 2018
∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingHamish Campbell, Nicholas Fleming, Imogen Roth, et al.
The Medical Journal of Australia|October 5, 2020
Outcomes for children after second liver transplantations are similar to those after first transplantations: a binational registry analysisAngus W Jeffrey, Gary P Jeffrey, Michael Stormon, et al.
Clinical Transplantation|December 13, 2023
Impact of Share 35 liver transplantation allocation in Australia and New ZealandMichael A Fink, Paul J Gow, Geoffrey W McCaughan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasisJoseph D Turner, Raman Sharma, Ghaith Al Jayoussi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2025
Incidence and risk factors for portal vein complications after pediatric liver transplantation: A retrospective cohort analysis from the PORTAL registryBader A Alfares, Lydia Sieben, Weihao Li, et al.
The New Zealand Medical Journal|February 17, 2017
Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?Boyd Swinburn, Stefanie Vandevijvere, Alistair Woodward, et al.
BMJ Open|July 27, 2023
Prevalence, management and efficacy of treatment in portal vein obstruction after paediatric liver transplantation: protocol of the retrospective international multicentre PORTAL registryBader A Alfares, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 8